Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Keaney

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Npj Drug Discovery|June 30, 2026
SARM1 base-exchange inhibitors induce SARM1 activation and neurodegeneration at low dosesAnisha Mani, Mateusz Mendel, Paul Westwood, et al.
Journal of Neuroinflammation|October 28, 2024
Fenebrutinib, a Bruton's tyrosine kinase inhibitor, blocks distinct human microglial signaling pathwaysJulie Langlois, Simona Lange, Martin Ebeling, et al.
Science Advances|October 23, 2015
Autoregulated paracellular clearance of amyloid-β across the blood-brain barrierJames Keaney, Dominic M Walsh, Tiernan O'Malley, et al.
Science Translational Medicine|January 31, 2024
Myeloid and lymphoid expression of <i>C9orf72</i> regulates IL-17A signaling in miceFrancesco Limone, Alexander Couto, Jin-Yuan Wang, et al.
Nature|June 3, 2020
C9orf72 suppresses systemic and neural inflammation induced by gut bacteriaAaron Burberry, Michael F Wells, Francesco Limone, et al.
Science Translational Medicine|April 4, 2014
IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degenerationSarah L Doyle, Ema Ozaki, Kiva Brennan, et al.
Nature Communications|May 24, 2012
Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injuryMatthew Campbell, Finnian Hanrahan, Oliviero L Gobbo, et al.
Theranostics|December 8, 2025
Translational molecular imaging and drug development in multiple sclerosisDaniel Tay, Hazem Ahmed, Alyaa Dawoud, et al.
Nature Communications|September 5, 2018
A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug targetPrashant K Srivastava, Jonathan van Eyll, Patrice Godard, et al.
Journal of Medicinal Chemistry|March 18, 2025
Discovery of a Potent SARM1 Base-Exchange Inhibitor with In Vivo EfficacyMaude Giroud, Bernd Kuhn, Sandra Steiner, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Npj Drug Discovery|June 30, 2026
SARM1 base-exchange inhibitors induce SARM1 activation and neurodegeneration at low dosesAnisha Mani, Mateusz Mendel, Paul Westwood, et al.
Journal of Neuroinflammation|October 28, 2024
Fenebrutinib, a Bruton's tyrosine kinase inhibitor, blocks distinct human microglial signaling pathwaysJulie Langlois, Simona Lange, Martin Ebeling, et al.
Science Advances|October 23, 2015
Autoregulated paracellular clearance of amyloid-β across the blood-brain barrierJames Keaney, Dominic M Walsh, Tiernan O'Malley, et al.
Science Translational Medicine|January 31, 2024
Myeloid and lymphoid expression of <i>C9orf72</i> regulates IL-17A signaling in miceFrancesco Limone, Alexander Couto, Jin-Yuan Wang, et al.
Nature|June 3, 2020
C9orf72 suppresses systemic and neural inflammation induced by gut bacteriaAaron Burberry, Michael F Wells, Francesco Limone, et al.
Science Translational Medicine|April 4, 2014
IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degenerationSarah L Doyle, Ema Ozaki, Kiva Brennan, et al.
Nature Communications|May 24, 2012
Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injuryMatthew Campbell, Finnian Hanrahan, Oliviero L Gobbo, et al.
Theranostics|December 8, 2025
Translational molecular imaging and drug development in multiple sclerosisDaniel Tay, Hazem Ahmed, Alyaa Dawoud, et al.
Nature Communications|September 5, 2018
A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug targetPrashant K Srivastava, Jonathan van Eyll, Patrice Godard, et al.
Journal of Medicinal Chemistry|March 18, 2025
Discovery of a Potent SARM1 Base-Exchange Inhibitor with In Vivo EfficacyMaude Giroud, Bernd Kuhn, Sandra Steiner, et al.
Pageof 2